QantaScope is a Swedish biotech company with the aims to make healthcare, and particularly cancer therapy, more efficient.
Our vision is to assist clinical cancer care based on new patient preselection methods and patented diagnostic platforms.
We also aim to assist pharmaceutical companies with their novel high throughput drug development and also guiding clinical trials, to improve hit rate with the help of patient preselection.
Our goal is to revolutionize routine pathology and methods based on morphological visualization, among others immunhistochemistry or histology by combining new OmniFluorBright™ (OFB) staining methods with automated digital image capture and analysis devices on a gigapixel scale.
Our new technologies are providing unsurpassed picture details of cell and tissue structures. These new platforms enable the user to further improve and develop the routine diagnostic laboratory workflow and achieve new levels of understanding of functional differences on a single cell and tissue levels.
Our expertise stretches over the following fields:
ASSAY GUIDED INDIVIDUALIZED CANCER CARE
DRUG DEVELOPMENT
ASSAY DEVELOPMENT FOR PATIENT PRESELECTION IN CLINICAL TRIALS
NEW TISSUE STAINING AND SCANNING TECHNOLOGIES
SCREENING OF NATURAL PRODUCT LIBRARIES
